Tumor cells activate platelets through direct cancer cell–platelet adhesion, and/or by tumor secretion of platelet-activating molecules (i.e., ADP, thrombin, matrix metalloproteinases, IL-6) which lead to platelet adhesion/aggregation [31]. This evidence concerns the gene IL6 and neoplasm.